A new study to be presented at the SLEEP 2025 annual meeting found that excessive daytime sleepiness is associated with higher odds of all-cause mortality in middle-aged women but not in younger or older women. Results show that the adjusted odds of all-cause mortality were 16% higher in women between […]
Research & Studies
Parental Engagement Associated with Better Sleep in Pre-teen Children
A new study to be presented at the SLEEP 2025 annual meeting found that strong family relationships and high parental engagement are among the aspects of social connectedness that are associated with sufficient sleep duration in pre-teen children. Results show that eating dinner with family and participating in neighborhood activities […]
Bridging Obesity Medicine and Sleep Medicine
Recent research has elevated the management of obesity in patients with sleep disorders to a prominent position in clinical practice. Obesity has been capturing attention across social media, mainstream news, and even in cultural references such as South Park specials and Jimmy Kimmel’s 2023 Oscars commentary. This heightened focus underscores […]
Apnimed Announces SynAIRgy Phase 3 Results
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of Apnimed’s lead […]
Panthera Dental Presents New Research at AADSM & SLEEP 2025
Panthera Dental is proud to announce that their abstracts were accepted for poster presentation at the AADSM and for poster and oral presentation at the SLEEP Annual Meetings. The oral presentation is part of a session entitled “Contemporary Management of Sleep Apnea” (O-13). Information regarding the 2025 IIR Grant will […]
Apnimed Groundbreaking SHINE Survey Reveals the Alarming Hidden Impact of OSA
Apnimed, Inc. announced the results of its Sleep Health Inquiries on Needs and Emotions (SHINE) survey of 1,500 people living with obstructive sleep apnea (OSA). The survey results revealed the significant and often devastating impact that people living with OSA experience daily. Many respondents reported feeling worn out or exhausted […]
Cranial Electrotherapy Stimulation May Impact Pain Processing, But Not Intensity
Veterans with fibromyalgia reported significant improvements in pain, sleep, mood, and overall health regardless of whether they received cranial electrotherapy stimulation (CES) or a sham treatment in a study out of Emory University in Atlanta, GA. However, brain activity demonstrated differences between the groups in regard to sensory and cognitive […]
Stanford Study Reveals AI-Enhanced Smartphone Facial Scans as a Novel Approach to Identifying Anatomical Contributors to Sleep Disorders
A pioneering study by sleep researchers at Stanford University, in collaboration with SoundHealth Inc., explores how smartphone facial scans powered by artificial intelligence can analyze facial structures linked to sleep disorders. This innovative approach uses smartphone cameras to assess craniofacial and maxillofacial features, shedding light on potential anatomical contributors to […]
New Brain-Based Measurement of Sleepiness Identified
At some point, many of us have experienced the post-lunch sleepy hour, struggling to stay alert mid-afternoon, and reaching for the water bottle to rehydrate a tired body. But what about those people who suffer from “excessive daytime somnolence”, aka sleepiness that lasts throughout the day? It’s a recognized medical […]
Cannabinoid-Based Sleep Apnea Treatment Begins Dosing in Phase 2/3 Trial
Incannex Healthcare Inc., a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies, is pleased to announce that patient dosing has commenced in the Company’s Phase 2/3 clinical trial to assess the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA). IHL-42X is the Company’s […]













